151 results about "Fat mass" patented technology

The present invention relates to a method and apparatus for removing body fat. While an obesity patient or person wants to remove body fat built up in a certain part is conducting aerobic exercise such as running with attaching a surface-attaching type catheter on the fat part, the apparatus resolves and removes body fat by applying pulses, whose frequency is 10~120 Hz, through the catheter, and changes the exercising condition based upon his or her heart rate and standard heart rate, thereby conducting efficient removal of body fat.

The present invention relates generally to an apparatus for managing the body fat of a human body and, more particularly, to a mobile communication terminal in which a body fat managing function is embedded, and an apparatus in which a body fat managing device is connected to a mobile communication terminal. The mobile communication terminal, in which a body fat managing function is embedded, includes a signal amplifying and converting unit for converting the measured value of body fat, a low frequency generating unit for generating low frequency waves, an input unit for receiving the body fat-related items, a display unit for displaying the measured value of the body fat, a memory unit for storing the measured value of the body fat, an adaptor unit connected to outside electrode lines, and a control unit for controlling the respective function units. Additionally, a body fat managing device, which is used while being connected to a mobile communication terminal, includes a signal amplifying and converting unit, a low frequency generating unit, an electrode unit and a conduction unit.

This invention is directed to a feed composition and method of affecting the carcass composition by increasing the lean mass, reducing the fat mass, and/or reducing the percent fat mass comprising SARM compounds.

The present invention relates to the unexpected discovery that a combination of effective amounts of carnitine (in any form, as described in further detail herein) and conjugated linoleic acid (CLA) administered to a patient in need thereof exhibits synergistic activity in treating obesity by reducing fat mass and overall weight as well as one or more of hyperlipidemia, hypercholesterolemia, diabetes (both diabetes mellitus I and II), metabolic syndrome (syndrome X), kidiney failure and high blood pressure, where those conditions exist.

The present invention relates to methods for prevention and/or treatment of metabolic disorders, post-menopausal obesity and conditions associated with high fat diet consumption including, obesity, body weight gain, fat mass formation, bone mineral content reduction, white adipose tissue weight gain, increased cholesterol levels, increased leptin levels, insulin resistance, type II diabetes, increased blood glucose levels, inflammatory diseases, cardiovascular diseases, fatty liver condition (accumulation of fat in the liver), decreased uncoupling protein-1 (UCP-1) levels and increased lipogenesis.

The present invention relates to the use of a growth hormone (GH) secretagogue, such as a ghrelin-like compound, for the preparation of a medicament for the prophylaxis or treatment of ghrelin deficiency, and/or undesirable symptoms associated therewith, in an individual at risk of acquiring partial or complete ghrelin deficiency resulting from a medical treatment and/or from a pathological condition. The present invention also relates to use of a secretagogue compound for the preparation of a medicament for the prophylaxis or treatment of one or more of: loss of fat mass, loss of lean body mass, weight loss, cachexia, loss of appetite, immunological dysfunction, malnutrition, disrupted sleep pattern, sleepiness, reduction in intestinal absorption and/or intestinal mobility problems in an individual suffering from, or at risk of suffering from, ghrelin deficiency. Furthermore, the present invention relates to the use of a secretagogue, such as a ghrelin-like compound, for the production of a medicament for preventing weight increase in an individual either: a) being converted from a hyperthyroidic state to euthyroid state, or b) in remission from being converted from a hyperthyroidic state to euthyroid state.

Disclosed is a method of increasing lean body mass and reducing fat body mass in infants, said method comprising administration to an infant, term or preterm, a nutritional formula comprising a source of DHA and ARA. It has been found that the administration of DHA and ARA, or a source thereof, in infants can increase lean body mass and reduce fat body mass, when compared to an unsupplemented control formula, without impacting the total overall growth of the infant. This method is especially useful in preterm infants.

The present disclosure relates, in one aspect, to use of ghrelin splice variant or an analogue thereof for the preparation of a medicament for one or more of: treatment and/or prevention of loss of body weight and body fat, prophylaxis or treatment of cachexia, stimulation of appetite, stimulation of food intake, stimulation of weight gain, or increasing body fat mass, or increasing body lean mass. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for the prophylaxis or treatment of cancer cachexia in an individual in need of such treatment. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for prophylaxis or treatment of cachexia in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to the use of a ghrelin splice variant-like compound or a pharmaceutically acceptable salt thereof for the preparation of a medicament for stimulation of appetite in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to a number of new ghrelin splice variant-like compounds and uses thereof, as well as to pharmaceutical compositions and medical packaging comprising the new ghrelin splice variant-like compounds.

The invention provides a method for wireless terminal networking based on a fat AP and a method for wandering among the fat APs. The networking method comprises the step that a wireless terminal requests obtaining of an IP address from a DHCP process of the fat AP; the DHCP process of the fat AP returns the IP and forwards an MAC address of the wireless terminal to an access control process; the access control process inquires a Portal server whether the MAC address of the wireless terminal passes authentication, and the access control process releases the wireless terminal and the wireless terminal can be connected to the Internet if the authentication is completed; if the authentication is not completed, the wireless terminal is then oriented to the Portal server for the authentication; if the wireless terminal passes the authentication, the access control process of the fat AP releases the wireless terminal, and the wireless terminal can be connected to the Internet; and if the wireless terminal does not pass the authentication, the access control process cannot release the wireless terminal, and the wireless terminal cannot be connected to the Internet. After the same terminal passes the authentication of the previous fat AP, the state of a Portal cloud terminal can be changed to completion of the authentication; the terminal does not need to pass the authentication of the next fat AP; and the wireless terminal can be connected and get access to the Internet without informing a user.

A fat mass measurement apparatus includes an area detection unit that detects a predetermined position in a measurement subject's trunk area and detecting a predetermined area in the trunk area using the detected position; an electrode position setting unit that sets, on the body surface at the predetermined area detected by the area detection unit, a plurality of positions along the vertical direction of the trunk area for measuring the body impedance; an impedance measurement unit that measures the body impedance by bringing the impedance measurement electrodes into contact with each of the plurality of positions that have been set; and an abdominal area fat mass calculation unit that calculates a fat volume at the predetermined area based on the body impedances at each of the plurality of positions measured by the impedance measurement and the size of the trunk area at the predetermined area.

The invention relates to purple sweet potato flaky pastry and a making method thereof, and belongs to the technical field of food. The purple sweet potato flaky pastry comprises, by weight, 100-150 parts of high-gluten flour, 50-60 parts of low-gluten flour, 100-120 parts of lotus seeds, 10-25 parts of white granulated sugar, 20-40 parts of sweet osmanthus honey, 30-50 parts of peanut oil, 50-60 parts of carrot juice, 50-80 parts of purple sweet potatoes, 20-28 parts of pumpkins, 10-15 parts of bacon, 5-8 parts of dried blueberries, 6-9 parts of dried mango and 5-9 parts of walnut kernels. The purple sweet potato flaky pastry is nutrient, healthy, reasonable in match and easy and convenient to make, has a little of fat mass, can be eaten by people at ease, can be eaten as dessert and staple food and can resist cancer if being eaten by people for a long time, so that the effect of purple sweet potatoes is sufficiently utilized, and purple sweet potatoes can be better developed and utilized.

A visceral fat area estimating system of the present invention comprises first input unit for inputting a height of an subject, second input unit for inputting a body weight of the subject, third input unit for inputting a fat mass of the subject, fourth input unit for inputting age of the subject, computation unit for computing a visceral fat area based on data from the first, second, third and fourth input unit, and display unit for displaying the visceral fat area computed by the computation unit. Therefore, the system can estimate a visceral fat area securely without concern for exposure of an subject to X-rays, at low costs, and with proper accuracy.

A body fat measurement device includes hand electrodes that contact both hands, back area electrodes that contact the surface of a trunk area of the back, foot electrodes that contact both feet, a trunk area width detection unit for measuring the width and depth of the trunk area, a body impedance measurement unit that measures the body impedance of a body using the multiple electrodes and a body fat mass calculation unit that calculates a body fat mass based on the body impedance and the width and depth of the trunk area. The back area electrodes that make contact with the surface of the back of the trunk area are provided in a fitting unit in an exposed state, as well as the trunk area width detection unit. Accordingly, a body fat measurement device can measure a body fat mass easily and accurately in a household or the like.

The invention discloses a fat-mass film-coated slow-release fertilizer comprising a fertilizer core and a fertilizer core outer capsule. The capsule is an amine resin-montmorillonite composite film or a composite layer of the amine resin-montmorillonite composite film and a degradable polymer film and can be compounded with a sulfur film and/or a high-resistance permeable organic film layer with preferable thickness not more than 20um; high-resistance permeable organic matter can be also mixed in the amine resin-montmorillonite composite film; the mass fraction of the montmorillonite in the high-resistance permeable organic film layer is preferably not more than 50% and optimally 0.5-30%; the total thickness of the capsule is preferably not less than 30um; and the thickness of the sulfur film is preferably 0-50um. The capsule body of the fat-mass film-coated slow-release fertilizer is (basically) harmless to the environment, is a fertilizer constituent and has low cost and long release period.

A method and an apparatus for judgment of physical constitution and physical strength for a person under test are described. The apparatus comprises a first input unit, a second input unit, and an arithmetic unit. According to the present invention the first input unit enters fat mass in a trunk of the person under test. The second input unit enters fat mass in lower limbs of the person under test. The arithmetic unit calculates Proportion Age based on the data entered from said first and second input units.

The invention discloses a rhein specific group modified organic compound, an aryl metal complex, a preparation method and application thereof. Compared with rhein molecules, the organic compound and metal complex have better antitumor and antibacterial activity, and the metal complex also can induce nucleic acid configuration transformation. Specifically, the aryl metal dimer and the above-mentioned metal complex both have good FTO (fat mass and obesity associated) inhibitory activity, and are good FTO inhibitors. The invention also discloses a synthesis method of the organic compound and themetal complex thereof, and the method has the characteristics of simple technological process, easy operation, and high yield. Finally, the invention discloses application of the rhein group-containing organic compound, the metal complex and aromatic metal dimer thereof in preparation of FTO inhibitor drugs, FTO inhibitor drug components, weight-reducing drugs, weight-reducing drug components, anticancer drugs, anticancer drug components, antibacterial drugs and antibacterial drug components.

The present invention relates to a pharmaceutical composition for the prevention and treatment of diabetes or obesity comprising as active ingredients a compound which inhibits the activity of dipeptidyl peptidase-IV (DPP-IV), a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof, and one or more other antidiabetic or antiobesity agents. The pharmaceutical composition exhibits excellent glucose tolerance and may be useful in the prevention and treatment of diabetes, obesity, and the like by effectively inhibiting blood glucose levels and reducing fat mass.

A body fat measurement device includes a plurality of electrodes including back area electrodes and upper limb electrodes, a body impedance measurement unit that measures a body impedance using the plurality of electrodes, a body composition information calculation unit that calculates a body fat mass based on the body impedance, a fitting belt for bringing the back area electrodes into contact with the surface of the measurement subject's back area in a pressurized state, and an upper limb unit that includes a gripping portion that can be gripped by the measurement subject's hand, the upper limb electrodes being provided in the gripping portion. The upper limb unit can be attached to and detached from the fitting belt.